293 filings
Page 4 of 15
8-K
ga00 4sxd5
30 Apr 20
Acasti Pharma Announces Submission of TRILOGY 1 Briefing Package to FDA
4:22pm
8-K
frgflnna1 vkl
20 Apr 20
Acasti Pharma Awarded Notice of Allowance for Second Composition of Matter Patent in Canada
4:05pm
8-K
ped5q7rr7mlkxk
1 Apr 20
Acasti Pharma Submits FDA Meeting Request on Schedule, and FDA Meeting Expected in the Second Half of June
5:12pm
6-K
npb28f293qzg3qz
11 Mar 20
Acasti Pharma Awarded Notice of Allowance for Additional Composition of Matter and Method of Use Patents in the United States and Mexico
8:00am
6-K
h1e5l3u9yt
28 Feb 20
Acasti Receives NASDAQ Notification Regarding Minimum Bid Requirements
5:00pm
6-K
uq5we2
14 Feb 20
Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2020
8:00am
6-K
8z435d
14 Feb 20
Current report (foreign)
8:00am
6-K
4r5wuv9kdu
13 Feb 20
Acasti Pharma Schedules Third Quarter Fiscal 2020 and Business Update Conference Call
9:00am
6-K
5ky817bp crsn6
10 Feb 20
Acasti Pharma Provides Update on TRILOGY 1 and TRILOGY 2 Phase 3 Trials of CaPre
7:00am
6-K
os1ng t7p89leuc
13 Jan 20
Acasti Pharma Reports Topline Results for TRILOGY 1 Phase 3 Trial of CaPre
6:21am
6-K
t065r8rva3j98o
23 Dec 19
Acasti Pharma Provides Update on Timing of Topline Results for TRILOGY 1 Phase 3 Trial of CaPre
8:43pm
6-K
2ayapml 7w6hsnwonbw
26 Nov 19
Acasti Pharma Reports Last Patient Visit in TRILOGY 1 Phase 3 Trial of CaPre for the Treatment of Severe Hypertriglyceridemia
7:58am
6-K
dyze hg80
18 Nov 19
Current report (foreign)
8:46am
6-K
uqvr3eo kkr
13 Nov 19
Current report (foreign)
7:55am
6-K
kvsib9qdwn741r5
13 Nov 19
Acasti Pharma Provides Business Update for the Second Quarter of Fiscal 2020
7:55am
6-K
9uz7pgi vubv
7 Nov 19
Acasti Pharma Announces Publication of CaPre Pharmacokinetics Study in a Leading Peer-Reviewed Journal
8:42am
6-K
o3dnifrbb d8wusik4e1
6 Nov 19
Acasti Pharma Schedules Second Quarter Fiscal 2020 Conference Call
9:39am
6-K
l4301
4 Nov 19
Agreement provides Acasti long-term supply of raw krill oil through commercialization
9:24am
6-K
9tqw h8a2mc
1 Oct 19
Acasti Pharma to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
9:00am
6-K
tyyf90irimnjylz
30 Sep 19
Nearly 80% of randomized patients have completed the studies
8:37am